Regulatory Operations Consulting Services

The role of regulatory operations has evolved significantly over the last decade. What was once considered an administrative role is now, a strategic function. However, the role of regulatory operations experts continues to be misunderstood by many of their colleagues in other functional areas.

Program and project management header Program and project management header
Business worker talking around laptop

What is Regulatory Operations?

Regulatory operations (RegOps) is a support function that is responsible for organizing and managing the flow of regulatory submissions. Regulatory operations professionals are tasked with managing, building, and sending submissions to the regulators in the electronic Common Technical Document (eCTD) format. Furthermore, Reg Ops teams must also ensure the eCTD is compiled in a compliant and validated format before it is submitted.

Regulatory Operations vs. Regulatory Affairs: What’s the Difference?

Regulatory Affairs encompasses the strategic and technical expertise to set regulatory strategy, to prepare and generate regulatory submissions, engage in interactions with regulatory bodies, including both strategic regulatory experience and expertise in functional areas such as chemistry, manufacturing, and controls (CMC), nonclinical, etc.

Business worker collaborating around a blackboard
Business worker sharing papers around a conference table

The Regulatory Operations team is tasked with compiling all of the documents developed by the Regulatory Affairs team into a complete submission in a format that is compliant with the relevant regulatory requirements and confirming that the applicable agency can receive and read the file as it is submitted.

Regulatory Affairs is the content-centered body that makes sure the text and data included in the submission comply with applicable regulatory standards; Reg Ops ensures that the submissions are compliant from a technical perspective.

Strategic Elements of Regulatory Operations

So, where does the strategic component of Regulatory Operations come in? 

Regulatory Information Management Systems (RIMS) & Process Implementation

One of the key responsibilities of a regulatory operations team is RIMS and process implementation, as it plays a crucial role in ensuring compliance, efficiency, and strategic decision-making.

Before purchasing a RIMS, it is critical that organizations complete the proper due diligence activities. One of the biggest mistakes an organization can make is purchasing a regulatory system prior to developing the process(es) the system is intended to work within. In order for a regulatory system to function optimally, it is important for the processes to drive the systems that are used.

ProPharma’s Regulatory Operations team has extensive experience and expertise in working with organizations to develop processes and select, purchase, and implement the appropriate regulatory systems.  

professionals-around-conference-table-smiling-pointing-at-papers-with-data-graphs

Submission Management

Hands holding pens working over layers of papers and post it notes

Regulators expect to receive submissions in a very specific format and those applications that are submitted in an organized and easy to navigate manner have a decreased likelihood of information requests. However, the eCTD format was developed with the intention of being a living document, which can make it difficult to keep organized if it is not approached strategically. It is critical that you consider the future state and sequences of the document from the beginning. If this strategic step is skipped initially, you risk the dossier becoming a big headache down the road, potentially creating larger consequences with the regulatory agency later in the process.

ProPharma’s Regulatory Sciences team is made up of the world’s most renowned scientists who are strategic by nature and begin every project with the end in mind. Our team of regulatory operations experts are no exception to this rule, which allows us to anticipate each client’s specific future needs and build the dossier accordingly. 

Gradient Image

Looking for More Regulatory Services?

ProPharma offers a full suite of services and solutions for all of your Regulatory needs.

ProPharma's Regulatory Operations Services

ProPharma's Regulatory Operations Phases including Offerings and Services

Electronic Publishing

ProPharma’s team of Regulatory Operations experts has profound experience preparing and submitting regulatory applications in electronic Common Technical Document (eCTD) format for pharmaceutical and biotechnology companies of all sizes.

Our experts have the unique ability to anticipate the future needs of our clients, allowing us to build a submission that is able to evolve and adapt as the product continues through the development lifecycle. We have vast expertise in the following areas:

  • Management and organization of CTD files, including regulatory correspondence files
  • Quality review of formatted submission-ready documents
  • Management of all submission meta-data within the CTD to ensure the regulators are able to navigate the submission and identify file types throughout the application
  • Management of all regulatory tools used to ensure compliance with the applicable regulatory body

ProPharma: Expert Regulatory Operations & eCTD Submission Consultants

ProPharma’s Reg Ops team is made up of extremely dynamic experts who bring a large breadth of experience, allowing us to provide our clients with submission support on a global scale, including in the US, Canada, throughout Europe, and the APAC region.

 

Our Regulatory Operations team is part of our global Regulatory Sciences team, working in tandem with the Regulatory Affairs experts who are developing the full regulatory strategy and compiling content for the regulatory submission. As such, ProPharma’s Regulatory Sciences team is uniquely positioned to assist companies in the development and submission of successful regulatory applications across the globe. 

The World's Leading Regulatory Consultancy

Interested in learning how we can help with your regulatory needs? Contact us today to learn about our track record of success with the regulatory agencies over the last 40 years and discuss how we can help you get to the next regulatory milestone. 

News & Insights

The Role of CROs in Clinical Research & Clinical Trials

August 21, 2025

The Role of CROs in Clinical Research & Clinical Trials

Explore the critical role of CROs in clinical trials, their services, and how they enhance efficiency and compliance in the research process.

Recruitment Strategies in FSP: Building Agile Teams to Drive Clinical Success

August 14, 2025

Recruitment Strategies in FSP: Building Agile Teams to Drive Clinical Success

Optimize your FSP recruitment strategy with ProPharma's agile, technology-driven approach to building efficient and adaptable clinical research teams.

The Moving Regulatory Landscape for Gene Therapy Trials in EU

August 12, 2025

The Moving Regulatory Landscape for Gene Therapy Trials in EU

Explore the evolving regulatory landscape for gene therapy clinical trials in the EU. Learn how to navigate GMO applications for AAV gene therapy trials.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study From Local Limits to Global Integration: Transforming Medical Information Services in Japan - ProPharma

August 21, 2025

From Local Limits to Global Integration: Transforming Medical Information Servic...

Discover how ProPharma transformed medical information services in Japan by integrating global alignment with localized expertise. By harmonizing processes, cross-training teams, and tailoring...

Case Study Simplifying Global MLR Review: Local Expertise at a Global Scale

August 4, 2025

Simplifying Global MLR Review: Local Expertise at a Global Scale

Struggling to streamline MLR review across international markets? Discover how our team helped a leading pharmaceutical company reduce review timelines, ensure regulatory compliance, and eliminate...

Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Navigating the Review Process: Optimizing MLR Meetings for Speed and Compliance

September 23, 2025

Navigating the Review Process: Optimizing MLR Meetings for Speed and Compliance

Discover how to run faster, more effective MLR review meetings without sacrificing compliance. Join us to learn practical strategies to streamline promotional review and accelerate approvals.

The Path to Clarity – Unlocking the Power of Data Standards for Digital Transformation

September 17, 2025

The Path to Clarity – Unlocking the Power of Data Standards for Digital Transformation

In today’s data-driven R&D environment, fragmented and incompatible data can stall innovation. This webinar, led by experts from ProPharma and CSL Behring, reveals how robust data standards,...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

News & Insights

The Role of CROs in Clinical Research & Clinical Trials

August 21, 2025

The Role of CROs in Clinical Research & Clinical Trials

Explore the critical role of CROs in clinical trials, their services, and how they enhance efficiency and compliance in the research process.

Recruitment Strategies in FSP: Building Agile Teams to Drive Clinical Success

August 14, 2025

Recruitment Strategies in FSP: Building Agile Teams to Drive Clinical Success

Optimize your FSP recruitment strategy with ProPharma's agile, technology-driven approach to building efficient and adaptable clinical research teams.

The Moving Regulatory Landscape for Gene Therapy Trials in EU

August 12, 2025

The Moving Regulatory Landscape for Gene Therapy Trials in EU

Explore the evolving regulatory landscape for gene therapy clinical trials in the EU. Learn how to navigate GMO applications for AAV gene therapy trials.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study From Local Limits to Global Integration: Transforming Medical Information Services in Japan - ProPharma

August 21, 2025

From Local Limits to Global Integration: Transforming Medical Information Servic...

Discover how ProPharma transformed medical information services in Japan by integrating global alignment with localized expertise. By harmonizing processes, cross-training teams, and tailoring...

Case Study Simplifying Global MLR Review: Local Expertise at a Global Scale

August 4, 2025

Simplifying Global MLR Review: Local Expertise at a Global Scale

Struggling to streamline MLR review across international markets? Discover how our team helped a leading pharmaceutical company reduce review timelines, ensure regulatory compliance, and eliminate...

Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Previous Resource Arrow Next Resource Arrow
Navigating the Review Process: Optimizing MLR Meetings for Speed and Compliance

September 23, 2025

Navigating the Review Process: Optimizing MLR Meetings for Speed and Compliance

Discover how to run faster, more effective MLR review meetings without sacrificing compliance. Join us to learn practical strategies to streamline promotional review and accelerate approvals.

The Path to Clarity – Unlocking the Power of Data Standards for Digital Transformation

September 17, 2025

The Path to Clarity – Unlocking the Power of Data Standards for Digital Transformation

In today’s data-driven R&D environment, fragmented and incompatible data can stall innovation. This webinar, led by experts from ProPharma and CSL Behring, reveals how robust data standards,...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Previous Webinar Arrow Next Webinar Arrow